Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 76 peer-reviewed journal articles Updated
Nephrology

Distal renal tubular acidosis (dRTA): A Patient Guide

At a Glance

Distal renal tubular acidosis (dRTA) prevents the kidneys from removing enough acid into urine, so acid builds up in the blood. It may be inherited or acquired, but consistent alkali treatment and monitoring can restore balance and help protect kidney, bone, and growth.

Distal renal tubular acidosis (dRTA) is a rare kidney condition that affects how your body manages its internal chemistry. Normally, the kidneys act as a sophisticated filtration and balancing system, removing excess acid from the blood and flushing it out through the urine. In a person with dRTA, the specialized “pumps” in the final section of the kidney’s filtering units fail to move this acid into the urine. As a result, acid builds up in the bloodstream—a state called metabolic acidosis—while the urine remains inappropriately alkaline [1][2].

The reasons why these kidney pumps stop working usually depend on when the condition is first discovered. In children, dRTA is typically an inherited condition caused by genetic mutations that provide the wrong “instructions” for building those acid pumps [3][4]. In adults, the condition is more often “acquired,” meaning the pumps were initially healthy but were later damaged by an autoimmune disease, such as Sjögren syndrome, or by certain medications and urological issues [5][6]. Regardless of the cause, the resulting chemical imbalance is the same, leading to symptoms like muscle weakness from low potassium, recurring kidney stones, and, in children, a significant slowdown in growth [7][8].

Living with dRTA requires a commitment to alkali therapy, which provides the body with the “buffers” it needs to neutralize excess acid [9]. While a diagnosis of a chronic condition can feel overwhelming, dRTA is highly treatable. When the blood’s acid-base balance is restored and maintained through individualized, consistent medication, treatment reduces the risk of serious complications, and issues like stunted growth and bone disease may be halted or improved [10][11]. By working closely with a nephrology team and staying consistent with daily management, people with dRTA can protect their kidney health and lead full, active lives [12].

In this guide

6 chapters

01

Starting Your Journey with dRTA

Learn what distal renal tubular acidosis (dRTA) means, why it happens, and how alkali treatment can protect growth, bone health, and kidney health over time.

02

The Biology and Diagnosis of dRTA

Learn how distal RTA causes metabolic acidosis, low potassium, kidney stones, and alkaline urine—and how blood and urine tests distinguish it from other causes.

03

Understanding the Causes: Is it Inherited or Acquired?

Learn whether distal renal tubular acidosis is inherited or acquired, including genetic causes, autoimmune disease, medications, testing, and hearing-loss risk.

04

Standard of Care and Treatment Options

Learn how distal renal tubular acidosis treatment uses alkali therapy, lab monitoring, potassium or sodium medicines, and newer extended-release Sibnayal.

05

Long-Term Health and Potential Complications

Learn about distal renal tubular acidosis complications, including kidney stones, bone disease, hearing loss, CKD, and warning signs of very low potassium.

06

Staying on Track: Monitoring and Daily Life

Learn how to monitor distal renal tubular acidosis (dRTA), manage daily alkali treatment, reduce stone risk, plan sick days, and support lifelong care.

Common questions in this guide

What happens in distal renal tubular acidosis?
In dRTA, the distal parts of the kidneys cannot move enough acid into the urine. Acid therefore builds up in the blood, while the urine remains more alkaline than expected.
Is distal RTA inherited or acquired?
In children, dRTA is often inherited because of genetic changes affecting the kidney’s acid-moving pumps. In adults, it is more often acquired after conditions such as Sjögren syndrome, certain medicines, or urological problems damage those pumps.
How is dRTA treated?
The main treatment is alkali therapy, which supplies buffers that neutralize excess acid. The dose and schedule are individualized, and consistent treatment can reduce complications and help protect growth, bones, and kidneys.
What symptoms and complications can dRTA cause?
dRTA can lead to low potassium and muscle weakness, recurring kidney stones, and slowed growth in children. Ongoing acid imbalance can also contribute to bone disease and increase risks to kidney health if it is not treated.
What monitoring is needed for dRTA?
Follow-up may include blood tests for bicarbonate and potassium, along with checks of kidney health and bone density. Depending on the person’s history, the care team may also monitor hearing.
Should I report sudden muscle weakness with dRTA?
Yes. Sudden or severe muscle weakness may signal a significant potassium problem and should be reported immediately. Follow your care team’s instructions for urgent evaluation and do not change treatment without guidance.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Distal renal tubular acidosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my/my child's clinical picture suggest a primary genetic condition or an acquired form caused by another health issue?
  2. 2.How do our current lab results compare to the target goals for bicarbonate and potassium?
  3. 3.What is the long-term plan for monitoring kidney health, bone density, and hearing?
  4. 4.Are there newer, long-acting treatment options that could help reduce the number of daily doses?

References

References (12)
  1. 1

    Hypokalemic Distal Renal Tubular Acidosis.

    Vallés PG, Batlle D

    Advances in chronic kidney disease 2018; (25(4)):303-320 doi:10.1053/j.ackd.2018.05.003.

    PMID: 30139458
  2. 2

    Intercalated Cell Depletion and Vacuolar H+-ATPase Mistargeting in an Ae1 R607H Knockin Model.

    Mumtaz R, Trepiccione F, Hennings JC, et al.

    Journal of the American Society of Nephrology : JASN 2017; (28(5)):1507-1520 doi:10.1681/ASN.2016020169.

    PMID: 27932475
  3. 3

    Acidosis and Deafness in Patients with Recessive Mutations in FOXI1.

    Enerbäck S, Nilsson D, Edwards N, et al.

    Journal of the American Society of Nephrology : JASN 2018; (29(3)):1041-1048 doi:10.1681/ASN.2017080840.

    PMID: 29242249
  4. 4

    Distal renal tubular acidosis: genetic causes and management.

    Soares SBM, de Menezes Silva LAW, de Carvalho Mrad FC, Simões E Silva AC

    World journal of pediatrics : WJP 2019; (15(5)):422-431 doi:10.1007/s12519-019-00260-4.

    PMID: 31079338
  5. 5

    Secondary distal renal tubular acidosis and sclerotic metabolic bone disease in seronegative spondyloarthropathy.

    Agrawal N, Mahata R, Chakraborty PP, Basu K

    BMJ case reports 2022; (15(3)) doi:10.1136/bcr-2021-248712.

    PMID: 35292549
  6. 6

    The genetic and clinical spectrum of a large cohort of patients with distal renal tubular acidosis.

    Palazzo V, Provenzano A, Becherucci F, et al.

    Kidney international 2017; (91(5)):1243-1255 doi:10.1016/j.kint.2016.12.017.

    PMID: 28233610
  7. 7

    Clinical evaluation of Chinese patients with primary distal renal tubular acidosis.

    Zhang C, Ren H, Shen P, et al.

    Internal medicine (Tokyo, Japan) 2015; (54(7)):725-30 doi:10.2169/internalmedicine.54.9421.

    PMID: 25832932
  8. 8

    Incomplete Distal Renal Tubular Acidosis and Kidney Stones.

    Fuster DG, Moe OW

    Advances in chronic kidney disease 2018; (25(4)):366-374 doi:10.1053/j.ackd.2018.05.007.

    PMID: 30139463
  9. 9

    Primary Distal Renal Tubular Acidosis: Toward an Optimal Correction of Metabolic Acidosis.

    Medina E, Ariceta G, Batlle D

    Clinical journal of the American Society of Nephrology : CJASN 2024; (19(9)):1212-1222 doi:10.2215/CJN.0000000000000535.

    PMID: 38967973
  10. 10

    Distal renal tubular acidosis: ERKNet/ESPN clinical practice points.

    Trepiccione F, Walsh SB, Ariceta G, et al.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2021; (36(9)):1585-1596 doi:10.1093/ndt/gfab171.

    PMID: 33914889
  11. 11

    6-year treatment follow-up with an extended-release alkaline formulation (Sibnayal®) in primary distal renal tubular acidosis.

    Bertholet-Thomas A, De Mul A, Bernardor J, et al.

    Orphanet journal of rare diseases 2025; (20(1)):431 doi:10.1186/s13023-025-03953-4.

    PMID: 40804680
  12. 12

    Treatment and long-term outcome in primary distal renal tubular acidosis.

    Lopez-Garcia SC, Emma F, Walsh SB, et al.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2019; (34(6)):981-991 doi:10.1093/ndt/gfy409.

    PMID: 30773598

This dRTA guide is for informational purposes only and does not constitute medical advice. A nephrology team should interpret your labs, confirm the cause, and tailor alkali therapy for you or your child.